| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/12/2013 | CN103146626A Genetically engineered bacterium for treating breast cancer and construction method and application |
| 06/12/2013 | CN103145968A Folate-conjugated polyethylene glycol monostearate, and preparation method and application thereof |
| 06/12/2013 | CN103145932A Long-circulating anti-tumor targeting drug carrier and preparation method thereof |
| 06/12/2013 | CN103145867A Anti-tumor biological polysaccharide |
| 06/12/2013 | CN103145864A Codonopsis pilosula uniform polysaccharide CPPib, preparation and application thereof |
| 06/12/2013 | CN103145863A Method of extracting cynomorium songaricum polysaccharide through enzyme treatment and preparation of cynomorium songaricum polysaccharide antineoplastic agents |
| 06/12/2013 | CN103145855A Matrix metallo-proteinase inhibitor polypeptide and application thereof |
| 06/12/2013 | CN103145849A Chimeric antigen receptor and its use |
| 06/12/2013 | CN103145847A Anti-CD20 antibody-monomethyl auristatin E conjugate, its preparation method and application |
| 06/12/2013 | CN103145844A A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/12/2013 | CN103145835A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/12/2013 | CN103145803A Polypeptide in specific binding with breast cancer brain metastases cells |
| 06/12/2013 | CN103145801A Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MTA1 (Tumor Metastasis Associated Antigen 1) and application thereof |
| 06/12/2013 | CN103145795A Cycloartane type triterpene compound and application thereof |
| 06/12/2013 | CN103145794A Cimicifuga triterpenoid compound and application thereof |
| 06/12/2013 | CN103145783A Method of extracting isoquercitrin, senecio cannabifolius less glycoside and senecio cannabifolius less polysaccharide from senecio cannabifolius less |
| 06/12/2013 | CN103145780A Preparation method of blueberry anthocyanin and application of blueberry anthocyanin prepared |
| 06/12/2013 | CN103145779A 3,5-dimethyl-8-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-oxo) heterochromatic original alkyl-1-one, preparation method and application thereof |
| 06/12/2013 | CN103145778A Compound, and preparation method and application thereof |
| 06/12/2013 | CN103145762A Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof |
| 06/12/2013 | CN103145759A Alizarin molybdenum complex, preparation method, and application thereof in preventing and treating cancers |
| 06/12/2013 | CN103145741A Bisindole compound and medical composition and preparation method and use thereof |
| 06/12/2013 | CN103145740A Sulfoxide alkaloid compound as well as preparation method and application for same |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145726A Longikaurin A as well as medicinal composition and application thereof |
| 06/12/2013 | CN103145725A Compound, and preparation method and application thereof |
| 06/12/2013 | CN103145723A 2-sec-butyl-5-hydroxy-4,8-dimethyl-7,8-dihydro-2H-pyran[4,3,2-ij] heterochromatic original ene-3(9[alpha]H)-one, preparation method and application thereof |
| 06/12/2013 | CN103145721A Compound, and preparation method and application thereof |
| 06/12/2013 | CN103145712A Substituted 8-[6-amino-3-pyridyl]xanthenes |
| 06/12/2013 | CN103145702A Aminopyrimidines useful as kinase inhibitors |
| 06/12/2013 | CN103145686A 3-(2-hydroxypropyl)-1,5-dimethyl-7-(2-methylbutyryl) cyclopentane[c]pyran-6(7H)-one, preparation method and application thereof |
| 06/12/2013 | CN103145684A 7-hydroxy-8(2-hydroxy-3-methylvaleryl)-3,7-dimethyl-7,8-dihydro-6H-heterochromatic original ene-6-one, preparation method and application thereof |
| 06/12/2013 | CN103145683A Compound, preparation method and application thereof |
| 06/12/2013 | CN103145677A Method for separating active ingredients from aquilaria sinensis lamina by utilizing high-speed countercurrent chromatography |
| 06/12/2013 | CN103145676A 7,4'-disubstituted isoflavone derivative and preparation method and application thereof |
| 06/12/2013 | CN103145667A 8-hydroxy-2-propyl original alkyl-4-ketone and 5,8-dihydroxy-2-propyl original alkyl-4-ketone, preparation method and application thereof. |
| 06/12/2013 | CN103145662A N-substituted animobutyrolactone derivatives and uses thereof |
| 06/12/2013 | CN103145636A 1,4-diacyl-3,6-diphenyl-1,4-dihydrotetrazine compound as well as preparation method and application thereof |
| 06/12/2013 | CN103145583A Raceme alkannin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative and preparation and application thereof |
| 06/12/2013 | CN103145530A Compound, and preparation method and application thereof |
| 06/12/2013 | CN103143035A Application of heteroatoms doped aqueous carbon quantum dot in preparation of photo-sensitizers for fluorescent imaging marking and photodynamic therapy (PDT) |
| 06/12/2013 | CN103143033A Targeting liver cell carrier and preparation method thereof |
| 06/12/2013 | CN103143031A Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 06/12/2013 | CN103143027A Preparation of hyaluronic-acid-based double-targeting nano-composite medicament and application of double-targeting nano-composite medicament |
| 06/12/2013 | CN103143026A Block copolymer mPEG-PLGA/amorphous calcium silicate hydrate composite nano material as well as preparation method and application thereof |
| 06/12/2013 | CN103143017A VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 06/12/2013 | CN103143014A Microwave thermo-seed material with nano-core-shell structure |
| 06/12/2013 | CN103143013A Photosensitive medicinal preparation containing amino poly-carboxylic acid modification tetraphenylporphyrin compound and purpose thereof |
| 06/12/2013 | CN103143004A Survivin peptide vaccine |
| 06/12/2013 | CN103143000A Recombinant human interferon alpha2b preparation |
| 06/12/2013 | CN103142995A Application of Anoplin in treatment of esophageal cancer |
| 06/12/2013 | CN103142994A Application of Anoplin in treatment of leukemia |
| 06/12/2013 | CN103142993A Application of Anoplin in treatment of liver cancer |
| 06/12/2013 | CN103142936A Chinese medicine composition for performing postoperation cooperative treatment on papillary adenoma epithelial atypical hyperplasia |
| 06/12/2013 | CN103142935A Traditional Chinese medicinal composition for treating lung cancer and liver cancer |
| 06/12/2013 | CN103142934A Traditional Chinese medicinal composition for treating lung cancer and liver cancer |
| 06/12/2013 | CN103142931A Traditional Chinese medicine composite for treating liver cancer and preparation method thereof |
| 06/12/2013 | CN103142909A Orally traditional Chinese medicine composition for treating lung cancers |
| 06/12/2013 | CN103142854A Chinese medicine composition for performing postoperation cooperative treatment on mammary intraepithelial neoplasia |
| 06/12/2013 | CN103142774A Application of total saponin extract of lobedfruit schizocapsarhizome in treatment of liver cancer and nasopharyngeal carcinoma |
| 06/12/2013 | CN103142762A Anti-cancer pharmaceutical composition and application thereof |
| 06/12/2013 | CN103142721A Method for extracting triterpenoid from anli pear |
| 06/12/2013 | CN103142711A Anti-cancer pharmaceutical composition, and preparation method as well as application thereof |
| 06/12/2013 | CN103142694A Ointment for treating skin cancer and preparation method of ointment |
| 06/12/2013 | CN103142691A Rabdosia rubescens stem aqueous extract and its preparation method, finger-prints and use as anti-tumor agent |
| 06/12/2013 | CN103142689A Rabdosia rubescens stem aqueous extract and its preparation method, finger-prints and use as free-radical scavenger |
| 06/12/2013 | CN103142688A Rabdosia rubescens stem aqueous extract and its preparation method, finger-prints and use as anti-inflammatory agent |
| 06/12/2013 | CN103142685A Method for extraction of total flavonoid aglycones from hickory leaves |
| 06/12/2013 | CN103142665A Method for extracting anticancer substance from arlia elata |
| 06/12/2013 | CN103142662A Method for extracting and purifying polyphenol from choerospondias axillaris peel |
| 06/12/2013 | CN103142661A Preparation method of inonqqus obliquus water-extract fine powder |
| 06/12/2013 | CN103142656A Application of bacteroides fragilis in preparing composition for preventing and treating colon cancer |
| 06/12/2013 | CN103142653A Pharmaceutical composition for treating skin cancer and preparation method thereof |
| 06/12/2013 | CN103142652A Venenum bufonis fat-soluble extract dry powder inhaler, and preparation method and application thereof |
| 06/12/2013 | CN103142651A Traditional Chinese medicine preparation for treating lung cancer and colorectal cancer |
| 06/12/2013 | CN103142650A Preparation and composition of inner-alpha inhibitor protein from human plasma for treatment |
| 06/12/2013 | CN103142649A Preparation method of amylose-coated I3<->-complexed silver-coated iron composite nanoparticles |
| 06/12/2013 | CN103142646A Application of valproic acid in preparation of multidrug resistance reversal agent of lung cancer resistance medicine |
| 06/12/2013 | CN103142639A Application of polysaccharide sulfate in medicament for treating breast cancer |
| 06/12/2013 | CN103142634A Spirulina phatensis polysaccharide and cynomorium songaricum polysaccharide preparation and manufacture method thereof and application thereof |
| 06/12/2013 | CN103142632A Macrolides and uses of macrolides |
| 06/12/2013 | CN103142626A Application of triacetyl glucal in preparation of antitumor drug |
| 06/12/2013 | CN103142624A Application of antibiotic tigecycline in preparing anti-cancer medicine |
| 06/12/2013 | CN103142621A Medical applications of four buxus alkaloids compounds |
| 06/12/2013 | CN103142620A Application of ursolic acid to antitumor immunity |
| 06/12/2013 | CN103142607A Preparation method of tegafur gimeracil oteracil potassium capsule |
| 06/12/2013 | CN103142601A Application of PCI (Percutaneous Coronary Intervention)-32765 for preparing anti-angiogenic medicines |
| 06/12/2013 | CN103142600A Weekly administration of dipeptidyl peptidase inhibitors |
| 06/12/2013 | CN103142594A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/12/2013 | CN103142593A Application of neurokinin receptor 2 antagonist to treatment of leukemia |
| 06/12/2013 | CN103142584A Application of polysubstituted 5-hydroxypyrrolidone compounds in preparation of antitumor medicines |
| 06/12/2013 | CN103142582A Application of flavone compound in preparation of medicines for preventing or treating tumors |
| 06/12/2013 | CN103142545A Enteric capsule of etoposide |
| 06/12/2013 | CN103142544A Ubenimex capsule composition and preparation method thereof |
| 06/12/2013 | CN103142533A Enteric coated tablet of etoposide |
| 06/12/2013 | CN103142530A Sustained-release tablet of etoposide |
| 06/12/2013 | CN103142528A Troche of chick embryo polysaccharide |
| 06/12/2013 | CN103142523A Dropping pills containing etoposide |
| 06/12/2013 | CN103142522A 一种依托泊苷片剂 One kind of etoposide tablet |
| 06/12/2013 | CN103142514A Lyophilized composition for injection containing thymalfasin and preparation method thereof |